Morning Market Losers
March 31, 2014 at 09:50 AM EDT
Prana Biotechnology (NASDAQ: PRAN) shares tumbled 70.79% to $2.88 on failed Phase 2 Alzheimer's trial results. Clean Diesel ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.